The Global Clinical Chemistry Analyzers Industry, valued at US$ 13.6 billion in 2022, is on the brink of an extraordinary growth phase, as highlighted in the latest report released by Future Market Insights (FMI). The industry’s robust trajectory, driven by an impressive Compound Annual Growth Rate (CAGR) of 4.8%, is projected to propel its market …